US › Healthcare

Cytosorbents Crp (CTSO)

US · Healthcare · Medical Devices

$4.80+4.35%

Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue

$9.6M

Revenue YoY

+0.2%

Net profit

$-4.4M

Profit YoY

-326.9%

EPS

$-0.07

EPS estimate

$-0.05

Net margin

-45.9%

EPS came in at -0.07 against a street estimate of -0.05 — a miss of 40.0%.

Key statistics

Market cap

$15.1M

Forward P/E

7.2

P/B

11.43

Book value

$-0.24

EPS (TTM)

$-5.80

52-week high

$17.00

52-week low

$2.84

50-day MA

$5.07

200-day MA

$9.30

Beta

1.48

Analyst view

Analysts rate Cytosorbents Crp a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $47.50.

Shareholding

Insiders

16.25%

Institutions

22.37%

Largest institutional holders

Fund	Stake
Avenir Corporation	8.23%
Neuberger Berman Group LLC	3.12%
Vanguard Capital Management, LLC	3.04%
CM Management, LLC	2.34%
BlackRock Inc	1.00%
Geode Capital Management, LLC	0.96%
Sargent Investment Group, LLC	0.88%
Pathstone Holdings LLC	0.79%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cytosorbents Crp — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-11-07.